Shirlene Badger is Patient Advocacy lead for EMEA at Illumina, Inc. In this role, she leads the Patient Advocacy strategy and engagement across the fields of rare and undiagnosed genetic disease, reproductive health and oncology. Trained as a medical sociologist, she spent over fifteen years leading academic research initiatives at the University of Cambridge and elsewhere that sought to elevate the impact of patient voice in the development and implementation of novel and experimental medical technologies.
France
Catherine Alix-Panabières, PhD Dr
Associate Professor at the Faculty of Medicine of the University of Montpellier
Director of the Laboratory Rare Circulating Human Cells (LCCRH) à l'Université et CHU de Montpellier
